While our study has only explored the role of α2,6 sialylation and ST6GAL1 in BTICs in vitro and in immunocompromised mouse models, we acknowledge the potential importance of ST6GAL1 and/or ST6GAL2 in the brain tumor microenvironment. The gene discussed is ST6GAL1; the disease is brain neoplasm.